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inhibiting RhoA/ROCK pathway, suppressing RhoA activities, downregulating
associated proteins and interfering with the formation of stress ﬁbers.
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Effects of Astragaloside IV on the SDF-1/CXCR4 Expression in Atherosclerosis
of ApoE-/-Mice Induced by Hyperlipaemia
Qin Hewei, Liu Ping
Longhua Hospital Afﬁliated to Shanghai University of TCM, (Shanghai 200032)
Objectives: Astragaloside IV (AsIV) is the major effective component extracted from
the Chinese herb Astragalus membranaceus, which has been widely used to treat
cardiovascular disease. Recent studies have shown that AsIV can potentially protect
the arteries from atherosclerosis, but the mechanisms of action are unknown. We
therefore examined the effects of AsIV on SDF-1, CXCR4 expressing content, SDF-1,
CXCR4 mRNA gene and protein expression in the high-fat diet ApoE-/- mice.
Methods: Thirty-nine 8-week-old male ApoE-/- mice were divided into Three groups:
model group, AMD3100 groups and AsIV group; Another Twelve 8-week-old inbred
C57BL/6 mice were used as the control group. Groups of mice were sacriﬁced at
12 weeks of treatment, the blood and the aorta were removed.TG, TC, HDL-C, LDL-
C levels of each group of mice were detected using large biochemical analyzer. Aortic
cross-section pathological damage of mice were detected using HE staining. Aortic
SDF-1, CXCR4 expression levels were quantiﬁed using western blotting and real-time
PCR. Protein and mRNA expression of the SDF-1, CXCR4 was quantiﬁed using
western blotting and real-time PCR. Using western blotting and real-time PCR to
quantify protein and mRNA expression of the bone marrow-derived endothelial
progenitor cells CXCR4 of in Each group mice.
Results: Biochemical analysis showed TG, TC, HDL-C and LDL-C levels in AsIV
group was signiﬁcantly better than that in Model group (P <0.05). The extent of
atherosclerosis in aortic of apoE-/-mice in AsIV group was signiﬁcantly lighter than
that in model group; and the SDF-1, CXCR4 expression of aortic reduced, showing
statistical signiﬁcance (P<0.05). Western blotting and real-time PCR demonstrated
Astragaloside IV signiﬁcantly down-regulated protein and mRNA expression of
SDF-1, CXCR4 (P<0.05 vs model group), showing statistical signiﬁcance. Consistent
with this, Astragaloside IV signiﬁcantly down-regulated protein and mRNA expres-
sion of CXCR4 of bone marrow-derived endothelial progenitor cell (P<0.05 vs model
group).
Conclusions: The protective effects of AsIV in atherosclerosis injury may be related
to the regulation of lipid metabolism disorders, down-regulation of SDF-1/CXCR4
biological axis expression. SDF-1/CXCR4 biological axis is probably one of targets
that astragaloside intervention atherosclerosis in ApoE-/- mice.
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Relationship between polymorphism of SOCS-3 and dyslipidemia in China
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Objectives: We investigated the relationship between the polymorphism of SOCS-3
and dyslipidemia of people from Uygur in Xinjiang, China.
Methods: This cross-sectional study included 1379 participants in a Hetian Xinjiang
Uygur population who were 30-70 years of age and were not from interracial mar-
riages of 3 generations; all subjects were genotyped (909 dyslipidemia subjects, 470
healthy subjects).
Results: Allele (P¼0.002) and genotype (P¼0.003) frequencies of the distribution of
rs12953258 was signiﬁcantly different between the dyslipidemia group and control
group. Between the total cholesterol (TC) abnormal group and control group, high-
density lipoprotein-cholesterol (HDL-C) abnormal group and control group, tri-
glycerides (TG) abnormal group and control group, the frequencies of genotype in
rs12953258 were signiﬁcantly different (P¼0.007, 0.012, 0.0004, respectively). Based
on the logistic regression analysis, genotype CA and AA of rs12953258 were inde-
pendent and risk factors for dyslipidemia in Uygur (CC vs CA; odds ratio¼1.48, 95%
conﬁdence interval 1.11-1.98, P¼0.008), (CC vs AA; odds ratio¼2.48, 95% conﬁ-
dence interval 1.07-5.79, P¼0.035). Genotype AA of rs12953258 merged with sub-
jects whose waist-hip ratio was abnormal, indicating the presence of dyslipidemia.
The frequency of haplotype 4 (H4) A-G-C in the dyslipidemia group was higher than
in the control group (8.44 vs 5.37%, P¼0.003).
Conclusions: rs12953258 site of the SOCS-3 gene showed a close relationship with
dyslipidemia in Uygur. Combining genotype AA with subjects whose waist-hip ratios
were abnormal will increase prevalence of dyslipidemia obviously.
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Association between the SOCS 3 gene polymorphisms and essential hypertension
of Uygur Xinjiang population
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and Lei Wang
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Objectives: To investigate the relationship between genetic polymorphisms of
SOCS3 and essential hypertension of Uygur Xinjiang population.C28 JACC Vol 64/16/Suppl C j OctobMethods: The study registed 921 Uygur (including 427 hypertension patients and 494
normotensives controls) from Hetian area hypertension epidemiological survey. The
representative determination of genotype variations were selected by TaqMan-PCR
method in Uygur subjects, the association between genetic variations of SOCS3 and
hypertension was analyzed by means of cross-sectional study.
Results: In the three representative variations genotyped, rs9914220, rs4969168,
rs12953258, all the research objects and control group were in Hardy-Weinberg
equilibrium for three polymorphisms. In population, there were signiﬁcant differ-
ences of genotype distribution between hypertension and control subjects in
rs9914220 polymorphisms (P¼0.009, P<0.001), and the frequency of CC was
signiﬁcantly higher than TT between hypertension patients and normotensives. But
there were no signiﬁcant differences of genotype distribution and allele frequencies
between two groups for rs4969168 and rs12953258 polymorphisms. After adjusted
by other risk factors for hypertension individuals in Uygur using logistic regression,
including age,body mass index (BMI), waist-hip ratio, fasting blood glucose (FBG),
Cholesterol (CHOL), Triglyceride (TG), low-density lipoprotein (LDL), high-density
lipoprotein (HDL), serum sodium, serum potassium, serum calcium,CC was still an
independent protective factor for hypertension in Uygur population (OR¼0.358,
95%CI 0.205-0.624, P¼0.021), so did CT (OR¼0.396, 95%CI 0.227-0.690,
P¼0.010). People more than 50 years old, male, overweight and obesity, High
triglycerides were signiﬁcant predictor factors associated with all hypertension
patients when comparing with controls. Further analysis found that the level of blood
pressure, LDL, total cholesterol, serum calcium related to homozygote TT were
higher than CC, that is to say the role of homozygote CC was reduce the risk of
hypertension.
Conclusions: This study reported that the SOCS3 gene may be one of the suscepti-
bility genes for essential hypertension. In the Uygur Xinjiang population, the carriers
of CC and CT genotypes at rs9914220 had reduced the level of blood pressure as well
as risks for essential hypertension.
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Association of glucose transporter 4 genetic Polymorphisms with obstructive
sleep apnea syndrome in Han Chinese general population: a cross-section study
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Ling Zhou, Guijuan Chang, Nanfang Li
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Objectives: Obstructive sleep apnea syndrome (OSAS) is strongly associated with the
increasing prevalence of cerebrovascular events and metabolic syndrome. A growing
number of studies have shown OSAS is an independent factor for insulin resistance,
glucose intolerance and type2 diabetes. However, relationship of OSAS with dysgly-
cemia is complex and still remains poorly understood. Glucose transporter 4 (GLUT4)
genes is Human and rodents’main glucose transporter sensitive to insulin, and therefore
conﬁrmation of candidate gene polymorphisms and association with OSAS is needed.
Aim of our study was to assess whether GLUT4 gene polymorphisms are associated
with OSAS.
Methods: Patients hospitalized at People’s Hospital of Xinjiang were selected from
January to December 2010. A total of 568 Han subjects who possibly exist OSAS base
on a history and physical examination were completed the polysomnography, 412of
whom (72.5%) were diagnosed with OSAS, and 156 individuals were conﬁrmed
without OSAS (27.5%). 96 severe OSAS patients chosen from OSAS were used for
DNA sequencing in functional domain. Blood samples were collected from all sub-
jects and genotyping was performed on DNA extracted from blood cells.
Results: We performed GLUT4 genome sequencing, found 4 mutated sites. And
ﬁnally selected three mutated sites such as rs5415, rs4517 and rs5435, according to
principle of linkage disequilibrium (r2 > 0.8) and minimum gene allele frequency
> 5%. All SNPs satisﬁed HEW (P > 0.05). Our study demonstrated a signiﬁcant
association of GLUT4 SNPrs5417 allele with OSAS, compared with controls
(P<0.05). Haplotype H1 (TCC) and H3 (CCC) deﬁned as SNPrs5415, rs4517 and
rs5435 are marginally associated with OSAS (P<0.05). Frequencies of C haplotype of
rs5417 in OSAS were higher than in controls. After adjustment for confounding
factors, (AC + AA) genotype signiﬁcantly reduces prevalence of OSAS, compared
with CC genotype. Level of awake blood oxygen and lowest blood oxygen of (AA +
AC) genotype was signiﬁcantly superior to those of CC genotype.
Conclusions: Our study demonstrates GLUT4 gene SNPrs5417 is associated with
OSAS in hypertensive population. Carriers of AA + AC have less prevalence of
obstructive sleep apnea syndrome than that of CC carriers.
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Objectives: Animal studies have demonstrated that scutellarin (SCU) limits damage
after myocardial ischemia injury. However, the underlying molecular mechanisms ofer 16–19, 2014 j GW-ICC Abstracts/Basic and Translational Medicine
SCU protecting against myocardial injury induced by ischemia reperfusion (IR) are
not well known. This study examined whether SCU protects against myocardial IR
injury is mediated by the Janus kinase and signal transducer and activator of tran-
scription (JAK/STAT) pathway.
Methods: Three models were used: a rat model of myocardial IR, an isolated thoracic
artery (TA) hypoxia reoxygenation (HR) model, and a human cardiac microvascular
endothelial cell (HCMEC) HR model. Protein and mRNA expression of JAK2/STAT3
and phosphorylative products were assessed by Western blot, immunohistochemistry
and RT-PCR method.
Results: In the rat myocardial IR model, SCU (45 and 90 mg/kg, iv) signiﬁcantly
reduced ischemic size, while immunohistochemical results showed that SCU signiﬁ-
cantly decreased histological phosphorylation JAK2 (P-JAK2) and STAT3 (P-
STAT3) expression. In isolated TA rings, pre-incubation with SCU (100, 500 mmol/
L) signiﬁcantly inhibited JAK2/STAT3 expression after HR. Western blot and RT-
PCR of HCMECs indicated that SCU (0.1, 1.0, 10 mmol/L) incubations signiﬁcantly
inhibited the phosphorylation of JAK2 and its downstream molecule STAT3 and in
contrast, HR up-regulated them.
Conclusions: SCU attenuates myocardial IR injury, at least in part, by inhibiting
injury-induced activation of JAK2/STAT3 signaling pathway.
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Suppression of PKCε-medicated mitochondrial connexin 43 phosphorylation at
serine 368 is involved in mitochondrial dysfunction in a rat model of dilated
cardiomyopathy
Shan Hu, Zhang Ming, Lin Lin, Yan Rui, Zhang Rong, Zhu Yanhe, Wei Jin
Department of Cardiology, The Second Afﬁliated Hospital, Xi’an Jiaotong University
Objectives: Mitochondrial connexin 43 (Cx43) plays an essential role in ischemic
preconditioning cardioprotection, however, it remains unclear whether mitochondrial
Cx43 is involved in mitochondrial dysfunction in the pathogenesis of dilated car-
diomyopathy (DCM). The present study was performed in order to investigate the
changes of the expression and phosphorylation state of mitochondrial Cx43 in a rat
model of DCM and to determine whether the altered mitochondrial Cx43 phosphor-
ylation state was involved in mitochondrial dysfunction.
Methods: The rat model of DCM was generated by daily oral administration of
furazolidone (FZD) for 30 weeks and was identiﬁed by echocardiographic studies.
The expression and phosphorylation state of mitochondrial Cx43 were examined by
western blot. The expression and activity of protein kinase C (PKC) ε were also
analyzed by western blot to reveal the underlying mechanism of Cx43 dephosphor-
ylation at serine 368. And then, the mitochondrial membrane potential level was
assessed using JC-1 by quantitative ﬂuorescence measurement. The activities of
cytochrome c oxidase and succinate dehydrogenase were determined by quantitative
colorimetric assay kit. The primary cultured neonatal rat cardiomyocytes were
sparsely plated without cell to cell contact and incubated with 100 nmmol/L phorbol-
12-myristate-13-acetate (PMA, a speciﬁc PKC activator) for 60 min after 48 h
FZD treatment to assess the effects of PKC activation on the FZD-induced mito-
chondrial Cx43 dephosphorylation and mitochondrial dysfunction. Pretreatment with
18b-glycerrhetinic acid (GA, a connexin channels inhibitor) for 4 h was performed to
determine the impact of mtCx43 suppression on PKC-activator induced mitochondrial
protection in the FZD-treated cardiomyocytes.
Results: Real-time PCR and western blot revealed the decreased expression of overall
Cx43 accompanied with lower level of serine 368-phosphorylated Cx43 immunoreac-
tivity in the myocardium and myocardial mitochondria. Meantime, mitochondrial mem-
brane potential level and the activities of cytochrome c oxidase, succinate dehydrogenase
and PKCεwere all reduced. PMApartially reversed theFZD-inducedmitochondrialCx43
dephosphorylation serine S368 and themitochondrial dysfunction in the cardiomyocytes.
However, pretreatment with GA abolished the mitochondrial protective effect of PMA in
the cardiomyocytes sparsely plated without cell to cell contact.
Conclusions: Our results suggest that mitochondrial Cx43 dephosphorylation at
serine 368 due to the suppression of PKCε activity may be a novel mechanism for
mitochondrial dysfunction in the pathogenesis of DCM.
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Investigation on Apoptosis of Vascular Endothelial Cells induced by Human
Cytomegalovirus via the Fas/FasL Pathway
Yue Yingying, Li Peng, Li Zhihui, Song Nannan, Li Bingqing, Meng Hong
Institute of Basic Medicine, Shandong Academy of Medical Sciences
Objectives: Human cytomegalovirus (HCMV) infection is associated with cardio-
vascular diseases, especially atherosclerosis. The detailed mechanisms were not fully
understood yet. Vascular endothelial cell injury has been suggested playing a key role
in the initiation and progression of atherosclerosis. This study is aiming to determine
whether HCMV infection can induce apoptosis in human umbilical vein endothelial
cells (HUVEC) via the Fas/FasL pathway, and lead to endothelial cell injury in vitro.
Methods: HUVEC were isolated and cultrured in vitro. DAPI staining method was
used to investigate the morphology of apoptotic HUVEC cells, and ﬂow cytometry
(FCM) to quantitatively detect the apoptotic rate. An antagonistic anti-Fas antibody
was applied to block apoptosis. The transcription of Fas mRNA in the HUVEC cells
infected by HCMV AD169 strain and corresponding cells were detected with RT-PCR
method. The expression of Fas was detected by FCM using FITC-conjugated
monoclonal antibody.JACC Vol 64/16/Suppl C j October 16–19, 2014 j GW-ICC Abstracts/BResults: Chromatin condensation and marginalization were found in HUVEC cells
infected with HCMV at 48 h and karyorrhexis started presenting in some cells, which
became more remarkable at 96 h. The apoptosis rates of HUVEC cells were 21.37%
and 55.83% at 48 h and 96 h, respectively, which were decreased to 8.26% and
17.65% after the cells were pretreated with the anti-Fas antibody. The transcriptional
level of Fas mRNA in HUVEC cells infected with HCMV AD169 strain showed a
strong uptrend over time compared with corresponding cells. Fas expression rates of
HUVEC cells rose up to 69.47% and 81.59%, respectively, compared with that of
10.35% and 13.67% in control groups at 48 h and 96 h.
Conclusions: HCMV AD169 strain can up-regulate Fas expression levels of HUVEC
cells and induce apoptosis of cells via Fas/FasL pathway. These results suggest that
Fas/FasL pathway may play a role in vascular endothelial cell injury and ultimately
lead to atherosclerosis.
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Role of GRK4 in the Regulation of Arterial AT1 Receptor in Hypertension
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Objectives: G protein-coupled receptor kinase 4 (GRK4) gene variants, via impair-
ment of renal dopamine receptor and enhancement of renin-angiotensin system
functions, cause sodium retention and increase blood pressure. Whether or not GRK4
and the angiotensin type 1 receptor (AT1R) interact in the aorta is not known.
Methods: GRK4 expression in vascular smooth muscle cells (VSMCs) of the aorta
was analyzed by confocal microscopy of double-stained, RT-PCR and immunoblot-
ting. AT1R protein expression and function in GRK4 variant 142V transfected A10
cells and WT cells was quantiﬁed by immunoblotting and AT1R-mediated intracel-
lular calcium concentration. AT1R phosphorylation level was determined by immu-
noprecipitation. The interaction between GRK4 and AT1R was determined by
immunoprecipitation and confocal microscopy of double-stained. NF-kB activity was
analyzed by electrophoretic mobility shift assay (EMSA). Angiotensin II-mediated
vasoconstriction of the aorta from 142V-transgentic mice and WT mcie was analyzed
by tension measurement of the artery rings.
Results:We report that GRK4 is expressed in vascular smooth muscle cells (VSMCs)
of the aorta. Heterologous expression of the GRK4g variant 142V in A10 cells
increased AT1R protein expression and AT1R-mediated increase in intracellular cal-
cium concentration. The increase in AT1R expression was related to an increase in
AT1R mRNA expression via the NF-kB pathway. As compared with control, cells
expressing GRK4g 142V had greater NF-kB activity with more NF-kB bound to the
AT1R promoter. The increased AT1R expression in cells expressing GRK4g 142V
was also associated with decreased AT1R degradation, which may be ascribed to
lower AT1R phosphorylation. There was a direct interaction between GRK4g wild-
type (WT) and AT1R that was decreased by GRK4g 142V. The regulation of AT1R
expression by GRK4g 142V in A10 cells was conﬁrmed in GRK4g 142V transgenic
mice; AT1R expression was higher in the aorta of GRK4g 142V transgenic mice than
control GRK4g wild-type (WT) mice. Angiotensin II-mediated vasoconstriction of the
aorta was also higher in GRK4g 142V than WT transgenic mice.
Conclusions: This study provides a mechanism by which GRK4, via regulation of
arterial AT1R expression and function, participates in the pathogenesis of conduit
vessel abnormalities in hypertension.
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Cardiac deacetylase SIRT3: A mitochondrial target for ischemia reperfusion
arrhythmia suppression
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Objectives: Ischemia reperfusion induces a high percentage of lethal arrhythmias.
Sirtuin 3 (SIRT3), a key nutrient sensing regulator by governing mitochondrial ho-
meostasis, was also reported to protect heart from reactive oxygen species (ROS)
assaults, but whether it is involved in ischemia reperfusion arrhythmias (IRA) and the
mechanism underlying remains unknown.
Methods: Sirt3 knockout (SIRT3 KO) mice and littermate wild-type (WT) mice were
assigned into sham group, ischemia reperfusion group (I/R) and I/R with NAD treated
group (7 days, 1 mg/kg/day) (NAD+I/R). Electrocardiography (ECG) was recorded
during I/R for arrhythmia score assessment, and cardiac reactive oxygen species
(ROS) production, SIRT3 and MnSOD levels were measured and analyzed.
Results: The results revealed that arrhythmia could be detected in sham SIRT3 KO
mice, and more serious arrhythmia was triggered by I/R in SIRT3 KO mice than WT
mice (P<0.05). Moreover, SIRT3 KO mice showed increased ROS production after
I/R compared with WT I/R mice (P<0.05), which was in accordance with decreased
manganese superoxide dismutase (MnSOD) and catalase (Cat) expression. NAD
treatment signiﬁcantly increased cardiac SIRT3 and MnSOD activity, inhibited ROS
production, and consequently suppressed IRA in WT mice, but failed in SIRT3 KO
mice.
Conclusions: These ﬁndings indicated that impairment of SIRT3 expression with
subsequent ROS production played an important role in IRA. Therefore, preserving
SIRT3 activity could be a potential approach to prevent IRA.asic and Translational Medicine C29
